{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:05:27Z","timestamp":1759741527606,"version":"3.37.3"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Major National Projects for Infectious Diseases Research","award":["2008ZX10002002","2012ZX10002-006-002-003"],"award-info":[{"award-number":["2008ZX10002002","2012ZX10002-006-002-003"]}]},{"name":"New Drug Research & Development","award":["2009ZX0913-710","2011AA02A114"],"award-info":[{"award-number":["2009ZX0913-710","2011AA02A114"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30571650","31370927"],"award-info":[{"award-number":["30571650","31370927"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Commission of Shanghai","award":["13431900602"],"award-info":[{"award-number":["13431900602"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.antiviral.2018.10.001","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T15:08:50Z","timestamp":1538492930000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Nasal immunization with RSV F and G protein fragments conjugated to an M cell-targeting ligand induces an enhanced immune response and protection against RSV infection"],"prefix":"10.1016","volume":"159","author":[{"given":"Inam Ullah","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiansheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naishuo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.10.001_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2014.01.022","article-title":"Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB\/c mice","volume":"104","author":"Bian","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.10.001_bib2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/eji.200839035","article-title":"Enhancing immune responses by targeting antigen to DC","volume":"39","author":"Caminschi","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2018.10.001_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12026-007-0071-6","article-title":"Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease","volume":"39","author":"Castilow","year":"2007","journal-title":"Immunol. Res."},{"key":"10.1016\/j.antiviral.2018.10.001_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12026-014-8540-1","article-title":"The CD4 T cell response to respiratory syncytial virus infection","volume":"59","author":"Christiaansen","year":"2014","journal-title":"Immunol. Res."},{"issue":"7","key":"10.1016\/j.antiviral.2018.10.001_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0264-410X(92)90397-3","article-title":"Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia\u2013RSV recombinants or RSV","volume":"10","author":"Connors","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.10.001_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.12.2.298","article-title":"Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment","volume":"12","author":"Domachowske","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2018.10.001_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.1136080","article-title":"Differential antigen processing by dendritic cell subsets in vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.antiviral.2018.10.001_bib8","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0264-410X(96)00030-8","article-title":"Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60","volume":"14","author":"Falsey","year":"1996","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.antiviral.2018.10.001_bib9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0264-410X(97)00002-9","article-title":"Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly","volume":"15","author":"Falsey","year":"1997","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.antiviral.2018.10.001_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1586\/erv.11.196","article-title":"Novel vaccine development strategies for inducing mucosal immunity","volume":"11","author":"Fujkuyama","year":"2012","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.antiviral.2018.10.001_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbrc.2011.12.046","article-title":"Notch-ligand expression by NALT dendritic cells regulates mucosal Th1- and Th2-type response","volume":"418","author":"Fukuyama","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.antiviral.2018.10.001_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaj1879","article-title":"Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors","volume":"1","author":"Gilman","year":"2016","journal-title":"Sci Immunol."},{"issue":"3","key":"10.1016\/j.antiviral.2018.10.001_bib13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.vaccine.2012.11.009","article-title":"Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine","volume":"31","author":"Glenn","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.antiviral.2018.10.001_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/archdischild-2015-308723","article-title":"Admission to hospital for bronchiolitis in England: trends over five decades, geographical variation and association with perinatal characteristics and subsequent asthma","volume":"101","author":"Green","year":"2016","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.antiviral.2018.10.001_bib15","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.201412-2256OC","article-title":"Impaired antibody mediated protection and defective IgA b-cell memory in experimental infection of adults with respiratory syncytial virus","volume":"191","author":"Habibi","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.antiviral.2018.10.001_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/600108","article-title":"Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB\/c mice","volume":"1200","author":"Haynes","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.10.001_bib17","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1099\/0022-1317-74-9-1995","article-title":"Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3","author":"Homa","year":"1993","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.10.001_bib18","first-page":"18e20","article-title":"Single primer-mediated circular polymerase chain reaction for hairpin DNA cloning and plasmid editing","author":"Huang","year":"2016","journal-title":"Anal. Biochem."},{"issue":"10","key":"10.1016\/j.antiviral.2018.10.001_bib19","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1586\/erv.11.120","article-title":"Respiratory syncytial virus vaccine development","volume":"10","author":"Hurwitz","year":"2011","journal-title":"Expert Rev. Vaccines"},{"issue":"108","key":"10.1016\/j.antiviral.2018.10.001_bib20","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1073\/pnas.1019547108","article-title":"Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A","volume":"8","author":"Idoyagaa","year":"2011","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2018.10.001_bib21","article-title":"Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis","author":"Jorquera","year":"2015","journal-title":"Expet Rev. Vaccine"},{"issue":"7","key":"10.1016\/j.antiviral.2018.10.001_bib22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1177\/2472555217690483","article-title":"Phage display-derived ligand for mucosal transcytotic receptor GP-2 promotes antigen delivery to M cells and induces antigen-specific immune response","volume":"22","author":"Khan","year":"2017","journal-title":"SLAS Discov."},{"issue":"4","key":"10.1016\/j.antiviral.2018.10.001_bib23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3349\/ymj.2016.57.4.809","article-title":"In hot pursuit of the first vaccine against respiratory syncytial virus","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med. J."},{"issue":"3","key":"10.1016\/j.antiviral.2018.10.001_bib24","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1038\/emm.2013.165","article-title":"Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines","volume":"46","author":"Kim","year":"2014","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.antiviral.2018.10.001_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7774\/cevr.2017.6.1.15","article-title":"The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants","volume":"6","author":"Kim","year":"2017","journal-title":"Clin. Exp. Vaccine Res."},{"issue":"10","key":"10.1016\/j.antiviral.2018.10.001_bib26","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.4049\/jimmunol.0903184","article-title":"The M cell-targeting ligand promotes antigen delivery and induces antigen-specific immune responses in mucosal vaccination","volume":"185","author":"Kim","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.10.001_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus PEYER'S-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"42","key":"10.1016\/j.antiviral.2018.10.001_bib28","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1016\/j.vaccine.2009.07.038","article-title":"A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age","volume":"27","author":"Langley","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.10.001_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.virol.2014.12.004","article-title":"Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease","volume":"476","author":"Lee","year":"2015","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.antiviral.2018.10.001_bib30","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.4049\/jimmunol.1502103","article-title":"A recombinant G protein plus cyclosporine A based respiratory syncytial virus vaccine elicits humoral and regulatory T cell responses against infection without vaccine-enhanced disease","volume":"196","author":"Li","year":"2016","journal-title":"J. Immunol."},{"issue":"20","key":"10.1016\/j.antiviral.2018.10.001_bib31","doi-asserted-by":"crossref","first-page":"10542","DOI":"10.1128\/JVI.05441-11","article-title":"A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection","volume":"85","author":"Lu","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.10.001_bib32","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/cti.2016.6","article-title":"Targeting dendritic cells: a promising strategy to improve vaccine effectiveness","volume":"5","author":"Macri","year":"2016","journal-title":"Clin. Trans. Immunol."},{"key":"10.1016\/j.antiviral.2018.10.001_bib33","first-page":"211","article-title":"Consequences of immature and senescent immune responses for infection with respiratory syncytial virus","volume":"372","author":"Malloy","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2018.10.001_bib34","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/382958","article-title":"Respiratory syncytial virus\u2013induced chemokine production: linking viral replication to chemokine production in vitro and in vivo","volume":"189","author":"Miller","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.10.001_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4049\/jimmunol.107.1.123","article-title":"Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness","volume":"107","author":"Mills","year":"1971","journal-title":"J. Immunol."},{"issue":"24","key":"10.1016\/j.antiviral.2018.10.001_bib36","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/S0264-410X(03)00352-9","article-title":"Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women","volume":"21","author":"Munoz","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.antiviral.2018.10.001_bib37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.14.2.430-445.2001","article-title":"Vaccination strategies for mucosal immune responses","volume":"14","author":"Ogra","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"issue":"10","key":"10.1016\/j.antiviral.2018.10.001_bib38","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/0264-410X(93)90131-G","article-title":"Vaccination with a heterologous respiratory syncytial virus chimeric FG glycoprotein demonstrates significant subgroup cross-reactivity","volume":"11","author":"Oien","year":"1993","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.antiviral.2018.10.001_bib39","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/00006454-199409000-00008","article-title":"Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old","volume":"13","author":"Paradiso","year":"1994","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2018.10.001_bib40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vetmic.2015.03.005","article-title":"Nasal immunization with M cell-targeting ligand-conjugated ApxIIA toxin fragment induces protective immunity against Actinobacillus pleuropneumoniae infection in a murine model","volume":"177","author":"Park","year":"2015","journal-title":"Vet. Microbiol."},{"issue":"19\u201320","key":"10.1016\/j.antiviral.2018.10.001_bib41","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/S0264-410X(03)00098-7","article-title":"Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis","volume":"21","author":"Piedra","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.10.001_bib42","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/mtm.2015.18","article-title":"Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates","volume":"2","author":"Pierantoni","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"7","key":"10.1016\/j.antiviral.2018.10.001_bib43","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1128\/JVI.73.7.5637-5645.1999","article-title":"Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein","volume":"73","author":"Plotnicky-Gilquin","year":"1999","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2018.10.001_bib44","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1128\/JVI.73.7.5637-5645.1999","article-title":"Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein","volume":"73","author":"Plotnicky-Gilquin","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.10.001_bib45","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/JVI.55.3.517-520.1985","article-title":"Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats","volume":"55","author":"Prince","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.10.001_bib46","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1128\/JVI.61.6.1851-1854.1987","article-title":"Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats","volume":"61","author":"Prince","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.10.001_bib47","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/infdis\/169.6.1368","article-title":"Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin","volume":"169","author":"Siber","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.10.001_bib48","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/JVI.61.12.3855-3861.1987","article-title":"Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus","volume":"61","author":"Stott","year":"1987","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2018.10.001_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1039\/a809656b","article-title":"A water-soluble tetrazolium salt useful for colorimetric cell viability assay","volume":"36","author":"Tominaga","year":"1999","journal-title":"Anal. Commun."},{"issue":"6","key":"10.1016\/j.antiviral.2018.10.001_bib50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0264-410X(94)90316-6","article-title":"Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement","volume":"12","author":"Tristram","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.10.001_bib51","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/421524","article-title":"Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults","volume":"190","author":"Walsh","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.10.001_bib52","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/pharmaceutics6030378","article-title":"Intranasal DNA vaccine for protection against Respiratory Infectious Diseases: the delivery perspectives","volume":"6","author":"Xu","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.antiviral.2018.10.001_bib53","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1128\/JVI.02372-07","article-title":"Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection","author":"Yu","year":"2008","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2018.10.001_bib54","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1128\/JVI.01755-09","article-title":"Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice","volume":"84","author":"Zhang","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.10.001_bib55","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1128\/JVI.01755-09","article-title":"Tripp. Vaccination to induce antibodies blocking the CX3C-CX3CR interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice","author":"Zhang","year":"2010","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218301104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218301104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T15:34:55Z","timestamp":1693928095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218301104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":55,"alternative-id":["S0166354218301104"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.10.001","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nasal immunization with RSV F and G protein fragments conjugated to an M cell-targeting ligand induces an enhanced immune response and protection against RSV infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}